CALB2 and Marinesco-Sjogren syndrome: However, the difference in CALB2 expression status in MSI and MSS subtypes remains unclear; consequently, further analysis of clinic-acquired COAD tissues was performed, displaying that CALB2 has a higher expression level in MSI samples which further indicated the therapeutic potential of CALB2.